Why Am I Gaining Weight on Wegovy? Common Causes

Weight gain or a stall on Wegovy typically comes down to your body adapting to the drug and to calorie restriction itself, not a failure of the medication. Semaglutide remains one of the most effective weight-loss drugs available, but biology doesn’t stop competing just because you start an injection. Metabolic slowdowns, shifts in body composition, receptor tolerance, underlying medical conditions, and even your genetics can all quietly work against the number on your scale.

Your Metabolism Fights Back Faster Than You Think

When you eat less, whether because of Wegovy’s appetite-suppressing effects or any other reason, your body starts conserving energy almost immediately. This process, sometimes called adaptive thermogenesis, means your daily calorie burn drops by more than you’d expect from weight loss alone. In one study of people on calorie restriction, energy expenditure fell by roughly 178 calories per day within the first week, above and beyond what the change in body size would predict.¹ That gap between how many calories your body “should” be burning and how many it actually burns is your metabolism trying to protect stored energy.

Semaglutide users are not exempt. The SEMALEAN study tracked body composition in patients with obesity on semaglutide and found that resting energy expenditure dropped by about 244 calories per day at seven months compared to baseline.² To put that in practical terms, that’s roughly the calorie content of a decent-sized snack, now invisible to you because your body silently stopped spending it. If your eating habits stay exactly the same after an initial weight-loss phase, this metabolic dip alone can cause your progress to stall or even reverse.

There is a partial rebound, though. By twelve months in the same study, resting energy expenditure climbed back up by about 140 calories per day compared to the seven-month low.² The slowdown is real, but it’s not necessarily permanent. Your body adjusts, and so can your approach.

Losing Muscle Along with Fat

Not all the weight you lose on Wegovy is fat. More than a quarter of total weight lost from both obesity medications and bariatric surgery typically comes from fat-free mass, which includes skeletal muscle.³ Muscle is metabolically expensive tissue. It burns calories around the clock, even when you’re sitting on the couch. When you lose a significant amount of it, your baseline calorie needs shrink, and weight loss naturally slows.

A large network meta-analysis of randomized trials confirmed that semaglutide produces pronounced muscle loss alongside fat loss due to decreases in fat-free mass.⁴ In the SEMALEAN study, lean mass dropped by about 3 kilograms (roughly 6.5 pounds) over the first seven months before stabilizing.² That stabilization is good news, but those lost pounds of muscle are a real contributor to a metabolic slowdown that can show up as a weight plateau or even a slight gain if calorie intake drifts upward.

This is especially concerning for older adults. Loss of muscle and bone during rapid weight loss can compromise physical function and metabolic rate, raising the risk of what researchers call sarcopenic obesity, where someone carries excess fat but has dangerously low muscle mass.³ Resistance training and adequate protein intake are the most practical defenses. They won’t eliminate muscle loss entirely during a caloric deficit, but they can meaningfully limit it.

What Your Scale Is Actually Showing You

A number going up on the scale doesn’t necessarily mean your body is gaining fat. Semaglutide shifts body composition in ways the scale can’t distinguish. One review found that while total and visceral fat mass proportions dropped by about 3.5% and 2.0% respectively, the proportion of lean body mass relative to total body mass actually increased by about 3%.⁵ So even when the drug is working well, the scale might not reflect that, especially if you’ve recently started exercising (muscle holds more water), shifted your sodium intake, or are retaining fluid for hormonal or other reasons.

Water weight fluctuations are among the most common culprits behind day-to-day or week-to-week scale changes. A salty meal, a change in medication, your menstrual cycle, constipation from Wegovy’s gastrointestinal side effects, or even the time of day you weigh yourself can create swings of several pounds. If your clothes fit the same or better but the scale crept up, you’re probably looking at a temporary fluid shift rather than genuine fat regain.

Receptor Tolerance Over Time

Wegovy works by mimicking a hormone called GLP-1, which binds to receptors in the brain and gut to reduce appetite and slow gastric emptying. But receptors are not endlessly responsive. Lab research has shown that when GLP-1 receptors are activated repeatedly at high levels, they can become desensitized, meaning they respond less strongly to the same signal.⁶ This phenomenon, sometimes called tachyphylaxis, has been documented in cell-based studies, though the exact degree to which it occurs in living patients at standard Wegovy doses is harder to pin down.

In practical terms, many Wegovy users report that the intense appetite suppression they experienced in the first few months gradually fades. You might notice hunger creeping back or find it easier to finish a full plate again. That doesn’t mean the drug has stopped working entirely, but it can mean the margin between how much you want to eat and how much your body actually needs has narrowed. When that happens, calories can inch up without any conscious change in behavior, and the scale responds.

This is one reason Wegovy is prescribed on a dose-escalation schedule. Starting at 0.25 mg and working up to 2.4 mg over several months gives your body time to adjust while progressively increasing the drug’s effect. If you stall at a lower dose, the next step up may restore some of the appetite suppression. But once you’ve reached the maximum dose and tolerance still develops, the options become more limited, and lifestyle adjustments carry more of the load.

Medications That Work Against Wegovy

Dozens of commonly prescribed medications promote weight gain as a side effect. If you started a new medication around the same time your Wegovy progress stalled, it’s worth investigating whether the two are working against each other. Some of the most frequent offenders include certain antidepressants (particularly older tricyclics and some SSRIs like paroxetine), antipsychotic medications, insulin and some other diabetes drugs like sulfonylureas, corticosteroids such as prednisone, beta-blockers for blood pressure, and some anticonvulsants. Each works through a different mechanism, whether it’s increasing appetite, promoting fat storage, causing fluid retention, or altering insulin dynamics, but the net effect can partially or fully counteract what Wegovy is doing.

This doesn’t mean you should stop any medication without talking to your prescriber. But it does mean that a full medication review is a reasonable step if you’re gaining weight on Wegovy despite doing everything else right. In many cases, alternatives exist that are weight-neutral or even mildly weight-favorable.

Underlying Medical Conditions

Certain health conditions can make weight loss harder regardless of what drug you’re taking. Hypothyroidism is one of the more common examples. An underactive thyroid slows metabolism and often causes salt and water retention, which adds visible pounds and physical puffiness that may be mistaken for fat gain. If your thyroid function hasn’t been checked recently and you’re gaining weight on Wegovy, a simple blood test can rule this out or confirm that treatment adjustments are needed.

Polycystic ovary syndrome (PCOS) is another condition that can complicate things. The hormonal imbalances involved, particularly insulin resistance, can make fat storage more efficient and weight loss more stubborn. Cushing’s syndrome, though rarer, directly increases cortisol levels and promotes central fat accumulation. Sleep apnea, which is common in people with obesity, disrupts sleep quality and hormonal regulation in ways that encourage weight gain. Even chronic stress, through its effect on cortisol, can blunt the progress Wegovy is designed to produce.

The point isn’t that any single condition explains every case of weight gain on Wegovy. It’s that these drugs work within the broader context of your biology, and unaddressed conditions create headwinds that semaglutide alone may not fully overcome.

The Role of Liquid Calories and Alcohol

Wegovy’s primary trick is suppressing appetite for solid food. You feel full faster, you think about food less, and portions naturally shrink. But liquid calories often fly under the radar. Sugary drinks, specialty coffees, smoothies, and alcohol deliver substantial energy without triggering the same fullness signals that solid food does. Many people on Wegovy report that their desire for food plummets but their coffee-shop habits or evening drinks don’t change.

Alcohol deserves a special mention. Beyond its calorie content (a standard glass of wine or beer runs 120 to 150 calories, cocktails often more), alcohol impairs your judgment around food, reduces your inhibitions, and can lead to snacking you wouldn’t otherwise do. There is growing research interest in whether GLP-1 receptor agonists like semaglutide might actually reduce alcohol consumption through their effects on brain reward pathways.⁷ Some users do report drinking less. But if you haven’t experienced that effect and your alcohol intake hasn’t changed, those calories are still landing, and your now-slower metabolism has less room to absorb them.

Missed Doses, Dose Gaps, and Stopping Treatment

Consistency with Wegovy matters more than many users realize. The STEP 1 trial extension tracked what happened after people stopped semaglutide following 68 weeks of treatment. Within a year of stopping, participants regained roughly two-thirds of the weight they had lost, averaging about 11.6 percentage points of regain.⁸ This wasn’t a slow trickle; it was a substantial rebound, accompanied by worsening cardiometabolic markers like blood pressure and blood sugar.

You don’t have to fully stop Wegovy to see this effect in miniature. Missing injections, running into supply shortages, or taking breaks for cost reasons all create gaps where the drug’s appetite-suppressing and metabolic effects fade. Even a few missed weeks can allow hunger to return and eating patterns to drift. If you’ve noticed weight gain that coincides with an interruption in your injection schedule, that connection is the most likely explanation.

The data also show that how much weight you had lost before stopping determines how much net benefit you retain. People who had lost 20% or more of their body weight before stopping semaglutide still showed a net loss of about 12% from their starting weight a year after stopping, while those who had lost less than 5% actually ended up slightly above their starting weight.⁸ Deeper initial losses seem to provide a larger cushion against regain.

Genetic Variation in Drug Response

Not everyone’s body responds to semaglutide the same way, and genetics are part of the reason. Early pharmacogenetic research has identified variants in the GLP-1 receptor gene itself that may influence how well the drug works. One variant, known as rs6923761 in the GLP1R gene, showed trends toward different weight and BMI changes in semaglutide users, though these trends were modest and didn’t reach statistical significance after corrections for multiple comparisons in the small group studied.⁹

This research is still in its infancy, and no genetic test currently available can reliably predict who will or won’t respond to Wegovy. But it does mean that some people are likely harder-wired to respond less dramatically, not because they’re doing anything wrong, but because their receptor biology is slightly different. In clinical trials, there is always a spread of outcomes. Some participants lose 20% of their body weight; others lose almost nothing. The reasons behind that spread are still being untangled, and genetics are almost certainly one thread.

How Semaglutide Changes Your Gut Bacteria

An emerging area of research involves the gut microbiome, the community of trillions of bacteria living in your intestines. These bacteria influence how efficiently you extract energy from food, how much fat your body stores, and how hunger signals are produced. Semaglutide appears to shift the balance of gut bacteria in ways that generally support weight loss, but the picture is complex and still developing.

In patients with type 2 diabetes, semaglutide treatment reduced the abundance of Firmicutes, a bacterial group linked to more efficient calorie extraction and fat storage, while increasing Bacteroidota species that produce compounds helping to suppress appetite and reduce fat production in the liver.¹⁰ On paper, these shifts should help with weight management. But there’s substantial individual variation in how gut bacteria respond, and factors like diet quality, fiber intake, antibiotic use, and stress can all influence whether these drug-related shifts actually stick.

If your diet on Wegovy has become very low in fiber because you’re eating less overall, that lack of prebiotic fuel could undermine the favorable microbiome shifts the drug otherwise promotes. Keeping some fiber-rich foods in your reduced diet, even in smaller amounts, may help preserve the gut bacterial balance that supports continued weight loss.

Compounded and Off-Brand Semaglutide

If you’re using compounded semaglutide from a telehealth service or compounding pharmacy rather than brand-name Wegovy, inconsistent dosing could be part of the problem. Compounded formulations are not subject to the same manufacturing standards as FDA-approved products, and the actual amount of active ingredient in each injection can vary. Some compounded products deliver lower effective doses than their label suggests, which means you may be getting less appetite suppression than you think.

There have also been FDA warnings about counterfeit semaglutide products entering the supply chain, some of which contained no semaglutide at all. If you’ve switched from brand-name Wegovy to a compounded version and noticed your weight plateau or gain, the formulation itself is a reasonable suspect. This isn’t an argument against compounded medications in all cases, but it is a variable worth considering that people on branded Wegovy don’t face.

When Reduced Activity Creates a Hidden Deficit

Semaglutide-related fatigue and muscle loss can quietly reduce how much you move throughout the day. You may not be skipping workouts, but if you’re sitting more, walking less, or generally moving with less energy, your total daily calorie burn drops. This non-exercise activity, everything from fidgeting to taking the stairs to walking around the grocery store, accounts for a surprisingly large chunk of the calories most people burn. When appetite drops dramatically and you’re eating much less, your body may compensate by reducing this spontaneous movement without you noticing.

The combination of eating less, losing some muscle, metabolic adaptation, and moving less can create a situation where your calorie expenditure shrinks almost as much as your calorie intake did. At that point, weight loss stalls even though you feel like you’re doing everything right. Tracking your daily step count or general movement patterns (even roughly) can help you spot this drift. If your steps have dropped from 8,000 to 4,000 since starting Wegovy, that gap represents a meaningful number of unburned calories each day.

Resistance training serves double duty here. It directly counteracts muscle loss, preserving the tissue that keeps resting metabolism higher, and it provides structured physical activity that isn’t as easily eroded by fatigue as spontaneous movement. Even two sessions a week can make a measurable difference in body composition and metabolic rate over the course of months on semaglutide.